PRQR Earnings & Financial Statements
ProQR Therapeutics N.V.
$1.47
-$0.01(-0.68%)
49
Overall
60
Value
45
Tech
42
Quality
Market Cap
$208.86M
Volume
1.08M
52W Range
$1.33 - $3.10
Target Price
$7.78
PRQR earnings and financial statements: ProQR Therapeutics N.V.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PRQR Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $16.35M | $19.55M | - | $4.04M | $1.35M |
| Cost of revenue | - | - | - | $69.52M | $59.59M |
| Operating income | -$43.45M | -$30.47M | - | -$70.61M | -$58.23M |
| EBITDA | -$38.17M | -$24.11M | - | -$62.27M | -$59.23M |
| Net income | -$42.18M | -$28.16M | - | -$128.78M | -$122.80M |
| EPS (diluted) | $-0.40 | $-0.32 | $-0.35 | $-0.91 | $-0.96 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRQR | $1.47 | -0.7% | 1.08M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |